Castle Biosciences Inc
CSTL· Nasdaq
CSTLCastle Biosciences Inc
Source filing unavailable
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Revenue | $8.72M | $3.66M |
| Net Income | -$1.36M | -$3.63M |
| EPS Diluted | -$1.22 | -$2.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR
